Register now to R3i !
Your Login
Your Password
Confirm Password  
Your Email
I agree to receive
the R3i newsletter

RECENT PUBLICATIONS ON RESIDUAL RISK

2018

Cost of diabetic complications in Germany

This new study underlines the economic impact of complications of type 2 diabetes in Germany, based on nationwide data from316,220 patients. Both cardiovascular and microvascular complications were associated with significant cost to the healthcare system, both in the short- and long-term. Specifically, estimated costs (in the 3 months subsequent to the event) were:
diabetic foot €1,293, amputation €14,284, retinopathy €671, blindness €2,933, nephropathy €3,353, end-stage renal disease (ESRD) €22,691, nonfatal stroke €9,769, fatal stroke €11,176, nonfatal myocardial infarction (MI)/cardiac arrest (CA) €8,035, fatal MI/CA €8,700, nonfatal ischemic heart disease (IHD) €6,548, fatal IHD €20,942, chronic heart failure €3,912, and angina pectoris €2,695. In the subsequent quarters, costs ranged from €681 for retinopathy to €6,130 for ESRD.
 
These data highlight the need for early intervention to prevent the debilitating consequences of complications of type 2 diabetes.
Health care costs associated with incident complications in patients with type 2 diabetes in Germany.

Kähm K, Laxy M, Schneider U et al.